Literature DB >> 28412141

Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation.

Frances Corrigan1, Alina Arulsamy2, Lyndsey E Collins-Praino2, Joshua L Holmes2, Robert Vink3.   

Abstract

A history of repeated concussion has been linked to the later development of neurodegeneration, which is associated with the accumulation of hyperphosphorylated tau and the development of behavioral deficits. However, the role that exogenous factors, such as immune activation, may play in the development of neurodegeneration following repeated mild traumatic brain injury (rmTBI) has not yet been explored. To investigate, male Sprague-Dawley rats were administered three mTBIs 5days apart using the diffuse impact-acceleration model to generate ∼100G. Sham animals underwent surgery only. At 1 or 5days following the last injury rats were given the TLR4 agonist, lipopolysaccharide (LPS, 0.1mg/kg), or saline. TLR4 activation had differential effects following rmTBI depending on the timing of activation. When given at 1day post-injury, LPS acutely activated microglia, but decreased production of pro-inflammatory cytokines like IL-6. This was associated with a reduction in neuronal injury, both acutely, with a restoration of levels of myelin basic protein (MBP), and chronically, preventing a loss of both MBP and PSD-95. Furthermore, these animals did not develop behavioral deficits with no changes in locomotion, anxiety, depressive-like behavior or cognition at 3months post-injury. Conversely, when LPS was given at 5days post-injury, it was associated acutely with an increase in pro-inflammatory cytokine production, with an exacerbation of neuronal damage and increased levels of aggregated and phosphorylated tau. At 3months post-injury, there was a slight exacerbation of functional deficits, particularly in cognition and depressive-like behavior. This highlights the complexity of the immune response following rmTBI and the need to understand how a history of rmTBI interacts with environmental factors to influence the potential to develop later neurodegeneration. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic traumatic encephalopathy; Concussion; Neurodegeneration; TLR4; Tau

Mesh:

Substances:

Year:  2017        PMID: 28412141     DOI: 10.1016/j.bbi.2017.04.006

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

1.  The effects of mild closed head injuries on tauopathy and cognitive deficits in rodents: Primary results in wild type and rTg4510 mice, and a systematic review.

Authors:  Adam D Bachstetter; Josh M Morganti; Colleen N Bodnar; Scott J Webster; Emma K Higgins; Kelly N Roberts; Henry Snider; Shelby E Meier; Grant K Nation; Danielle S Goulding; Matthew Hamm; David K Powell; Moriel Vandsburger; Linda J Van Eldik; Jose F Abisambra
Journal:  Exp Neurol       Date:  2020-01-11       Impact factor: 5.330

Review 2.  Inflammation in Traumatic Brain Injury.

Authors:  Teodor T Postolache; Abhishek Wadhawan; Adem Can; Christopher A Lowry; Margaret Woodbury; Hina Makkar; Andrew J Hoisington; Alison J Scott; Eileen Potocki; Michael E Benros; John W Stiller
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.

Authors:  Xiangrong Chen; Shukai Wu; Chunnuan Chen; Baoyuan Xie; Zhongning Fang; Weipeng Hu; Junyan Chen; Huangde Fu; Hefan He
Journal:  J Neuroinflammation       Date:  2017-07-24       Impact factor: 8.322

Review 4.  The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease.

Authors:  Olga N Kokiko-Cochran; Jonathan P Godbout
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

5.  Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits.

Authors:  Terez Shea-Donohue; Alan I Faden; Marie Hanscom; David J Loane; Taryn Aubretch; Jenna Leser; Kara Molesworth; Nivedita Hedgekar; Rodney M Ritzel; Gelareh Abulwerdi
Journal:  J Neuroinflammation       Date:  2021-01-18       Impact factor: 8.322

Review 6.  The Immune System's Role in the Consequences of Mild Traumatic Brain Injury (Concussion).

Authors:  Laura N Verboon; Hiren C Patel; Andrew D Greenhalgh
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury.

Authors:  Rishabh Sharma; Akram Zamani; Larissa K Dill; Mujun Sun; Erskine Chu; Marcus J Robinson; Terence J O'Brien; Sandy R Shultz; Bridgette D Semple
Journal:  J Neuroinflammation       Date:  2021-03-17       Impact factor: 8.322

8.  Effects of Remote Immune Activation on Performance in the 5-Choice Serial Reaction Time Task Following Mild Traumatic Brain Injury in Adolescence.

Authors:  Lola Kaukas; Justin Krieg; Lyndsey Collins-Praino; Frances Corrigan
Journal:  Front Behav Neurosci       Date:  2021-04-01       Impact factor: 3.558

9.  Electroacupuncture Attenuated Anxiety and Depression-Like Behavior via Inhibition of Hippocampal Inflammatory Response and Metabolic Disorders in TNBS-Induced IBD Rats.

Authors:  Feini Zhou; Hao Jiang; Ning Kong; Jiangnan Lin; Fan Zhang; Ting Mai; Zhijian Cao; Maosheng Xu
Journal:  Oxid Med Cell Longev       Date:  2022-01-18       Impact factor: 6.543

10.  Neural stem cell therapy in conjunction with curcumin loaded in niosomal nanoparticles enhanced recovery from traumatic brain injury.

Authors:  Abdolreza Narouiepour; Alireza Ebrahimzadeh-Bideskan; Ghadir Rajabzadeh; Ali Gorji; Sajad Sahab Negah
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.